Detalles de la búsqueda
1.
Pathogenesis and outcome of VA1 astrovirus infection in the human brain are defined by disruption of neural functions and imbalanced host immune responses.
PLoS Pathog
; 19(8): e1011544, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37595007
2.
A phase 2 study of pembrolizumab after autologous stem cell transplantation in patients with T-cell non-Hodgkin lymphoma.
Blood
; 142(7): 621-628, 2023 08 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-37319432
3.
Autologous transplant vs chimeric antigen receptor T-cell therapy for relapsed DLBCL in partial remission.
Blood
; 139(9): 1330-1339, 2022 03 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34570879
4.
Fecal microbiota diversity disruption and clinical outcomes after auto-HCT: a multicenter observational study.
Blood
; 137(11): 1527-1537, 2021 03 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-33512409
5.
Impact of conditioning regimen intensity on the outcomes of peripheral T-cell lymphoma, anaplastic large cell lymphoma and angioimmunoblastic T-cell lymphoma patients undergoing allogeneic transplant.
Br J Haematol
; 197(2): 212-222, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35106754
6.
Current Treatment of Peripheral T-cell Lymphoma.
Oncology (Williston Park)
; 36(5): 293-305, 2022 05 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35576176
7.
Effect of time to relapse on overall survival in patients with mantle cell lymphoma following autologous haematopoietic cell transplantation.
Br J Haematol
; 195(5): 757-763, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34581433
8.
CD19 CAR T cells following autologous transplantation in poor-risk relapsed and refractory B-cell non-Hodgkin lymphoma.
Blood
; 134(7): 626-635, 2019 08 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31262783
9.
Toxicity and response after CD19-specific CAR T-cell therapy in pediatric/young adult relapsed/refractory B-ALL.
Blood
; 134(26): 2361-2368, 2019 12 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-31650176
10.
Pilot Study of Telehealth Evaluations in Patients Undergoing Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant
; 26(6): e135-e137, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32070723
11.
A phase 1 study of ibrutinib in combination with R-ICE in patients with relapsed or primary refractory DLBCL.
Blood
; 131(16): 1805-1808, 2018 04 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-29386196
12.
Hematopoietic-cell transplantation for lymphoma in the era of genetically engineered cellular therapy: it's not quite time to scrap the old vehicle for the new car.
Curr Opin Hematol
; 26(4): 288-293, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31170111
13.
ASBMT Statement on Routine Prophylaxis for Central Nervous System Recurrence of Acute Lymphoblastic Leukemia following Allogeneic Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant
; 25(3): e86-e88, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30590125
14.
Hematopoietic Cell Transplantation in the Treatment of Adult Acute Lymphoblastic Leukemia: Updated 2019 Evidence-Based Review from the American Society for Transplantation and Cellular Therapy.
Biol Blood Marrow Transplant
; 25(11): 2113-2123, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31446198
15.
Allogeneic haematopoietic cell transplantation impacts on outcomes of mantle cell lymphoma with TP53 alterations.
Br J Haematol
; 184(6): 1006-1010, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30537212
16.
Longitudinal cognitive assessment in patients with primary CNS lymphoma treated with induction chemotherapy followed by reduced-dose whole-brain radiotherapy or autologous stem cell transplantation.
J Neurooncol
; 144(3): 553-562, 2019 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-31377920
17.
Distinctive Infectious Complications in Patients with Central Nervous System Lymphoma Undergoing Thiotepa, Busulfan, and Cyclophosphamide-conditioned Autologous Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 24(9): 1914-1919, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29679773
18.
Outcomes of Relapsed and Refractory Primary Mediastinal (Thymic) Large B Cell Lymphoma Treated with Second-Line Therapy and Intent to Transplant.
Biol Blood Marrow Transplant
; 24(10): 2133-2138, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29909154
19.
A Comprehensive Assessment of Toxicities in Patients with Central Nervous System Lymphoma Undergoing Autologous Stem Cell Transplantation Using Thiotepa, Busulfan, and Cyclophosphamide Conditioning.
Biol Blood Marrow Transplant
; 23(1): 38-43, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27713090
20.
T Cell Depletion as an Alternative Approach for Patients 55 Years or Older Undergoing Allogeneic Stem Cell Transplantation as Curative Therapy for Hematologic Malignancies.
Biol Blood Marrow Transplant
; 23(10): 1685-1694, 2017 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-28734876